A Case Report of Improvement of Docetaxel-induced Fluid Retention in a Patient with Advanced Gastric Cancer using Herbal Decoction, Modified Bangkihwangki-tang |
Choi, Seong-Heon
(Cancer center of Traditional Korean Medicine, Kyung Hee University hospital at Gangdong)
Lee, Jee Young (Cancer center of Traditional Korean Medicine, Kyung Hee University hospital at Gangdong) Lee, Sung-Un (Graduate school of Clinical Korean Medicine, Kyung Hee University) Lee, Soo-Min (Graduate school of Clinical Korean Medicine, Kyung Hee University) Park, Sora (Graduate school of Clinical Korean Medicine, Kyung Hee University) Jung, Yee-Hong (Graduate school of Clinical Korean Medicine, Kyung Hee University) |
1 | Amathieu R, Tual L, Fessenmeyer C, Dhonneur G. Docetaxel-induced acute pulmonary capillary -leak syndrome mimicking cardiogenic oedema. Ann Fr Anesth Reanim. 2007;26(2):180. DOI |
2 | Ohnishi N, Nagasawa K, Yokoyama T. The verification of regulatory effects of Kampo formulations on body fluid using model mice. Journal of Traditional Medicines. 2000;17(3):131-136. |
3 | Kim CU, Ryu DG, Lee EJ. The effects of Bangkihwangki-tang on renal functions in rabbit. The Korean Journal of Oriental Medical Prescription. 1990;1(1):183-195. |
4 | Gautam M, Atsushi I, Tatsuya S, Saeko Y, Hirohiko M, Takeshi T, et al. The Traditional Japanese Medicine (Kampo) Boiogito has a Dual Benefit in Cardiorenal Syndrome: A Pilot Observational Study. Shinshu Med J. 2014;62:89-97. |
5 |
Park JH, Bose S, Lim CY, Kim HJ. Impact of GNB3, ADRB3, UCP2, and PPAR |
6 | Majima T, Inoue M, Kasahara Y, Onodera T, Takahashi D, Minami A. Effect of the Japanese herbal medicine, Boiogito, on the osteoarthritis of the knee with joint effusion. Sports Med Arthrosc Rehabil Ther Technol. 2012;4(3). |
7 | Chen G, Liu H, Cheng F. Fangjihuangqi tang improved lower urinary tract dysfunction in benign prostatic hyperplasia rats model. J Tradit Chin Med. 2013;33(3):349-54. DOI |
8 | Cortes JE, Pazdur R. Docetaxel. J Clin Oncol. 1995;13(10):2643. DOI |
9 | Burris HA. Optimal use of docetaxel (Taxotere): maximizing its potential. Anticancer Drugs. 1996;7 Suppl 2:25-28. DOI |
10 | Chan S, Friedrichs K, Noel D, Pinter T, Van BS, Vorobiof D, et al. Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer. J Clin Oncol. 1999;17(8):2341-54. DOI |
11 | Behar A, Pujade-Lauraine E, Maurel A, Brun MD, Chauvin FF, Feuilhade de CF, et al. The pathophysiological mechanism of fluid retention in advanced cancer patients treated with docetaxel, but not receiving corticosteroid comedication. Br J Clin Pharmacol. 1997;43(6):653-8. DOI |
12 | Semb KA, Aamdal S, Oian P. Capillary protein leak syndrome appears to explain fluid retention in cancer patients who receive docetaxel treatment. J Clin Oncol. 1998;16(10):3426-32. DOI |
![]() |